Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00845
|
|||||
| Drug Name |
Daidzein
|
|||||
| Synonyms |
7-Dihydroxyisoflavone; 4',7-Dihydroxy-iso-flavone; 4',7-Dihydroxyisoflavone; 4,7-Dihydroxyisoflavone; 486-66-8; 4H-1-Benzopyran-4-one, 7-hydroxy-3-(4-hydroxyphenyl)-; 7,4'-Dihydroxyisoflavone; 7,4'-dihydroxyisoflavone; 7-Hydroxy-3-(4-hydroxyphenyl)-4-benzopyrone; 7-Hydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; 7-hydroxy-3-(4-hydroxyphenyl)-4H-chromen-4-one; 7-hydroxy-3-(4-hydroxyphenyl)chromen-4-one; BRN 0231523; CCRIS 7600; CHEMBL8145; DIADZEIN; Daidzein; Daidzeol; EINECS 207-635-4; K 251b; UNII-6287WC5J2L; d-(+)-alpha-methylbenzylamine
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Low Serum Lipid Levels [ICD11: 5C81] | Phase 4 | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C15H10O4
|
|||||
| Canonical SMILES |
C1=CC(=CC=C1C2=COC3=C(C2=O)C=CC(=C3)O)O
|
|||||
| InChI |
InChI=1S/C15H10O4/c16-10-3-1-9(2-4-10)13-8-19-14-7-11(17)5-6-12(14)15(13)18/h1-8,16-17H
|
|||||
| InChIKey |
ZQSIJRDFPHDXIC-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 486-66-8
|
|||||
| Pharmaceutical Properties | Molecular Weight | 254.24 | Topological Polar Surface Area | 66.8 | ||
| Heavy Atom Count | 19 | Rotatable Bond Count | 1 | |||
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 4 | |||
| XLogP |
2.5
|
|||||
| PubChem CID | ||||||
| ChEBI ID |
CHEBI:28197
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | BCRP | Transporter Info | Breast cancer resistance protein | Substrate | [2] | |
| References | ||||||
| 1 | ClinicalTrials.gov (NCT01497977) Phytoestrogen Supplementation in Postmenopausal Women | |||||
| 2 | Effect of breast cancer resistance protein (Bcrp/Abcg2) on the disposition of phytoestrogens. Mol Pharmacol. 2007 Oct;72(4):967-75. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.